Dec 18 () - Japan's Takeda Pharmaceutical said on Thursday its experimental pill for a type of skin disease, developed using ​artificial intelligence, succeeded in two late-stage studies. More than half ‌the plaque psoriasis patients across the studies showed clear or almost clear skin after ‌16 weeks of treatment with the once-daily drug, zasocitinib, the company said.

It comes as the U.S. surpassed 2,000 measles cases for the 1st time in 33 years.

Maxwell Kruzic said he was in such “crippling” stomach pain Oct. 5, 2023, that he had to pull off the road twice as he drove himself to the emergency room at Mercy Regional Medical Center in Durango, Colorado. “It was the worst pain of my life,” he said. Kruzic was seen immediately because hospital staff members were pretty sure he had appendicitis. They inserted an IV, called a surgeon and sent him off for a scan to confirm the diagnosis.Subscribe to The Post Most newsletter for the most import